CEO O/S at the moment. Maybe some interest from the offshore holders. Need some concrete news re cash flow and some will come soon particularly re the TB deal.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%